EVANS-FREKE STEPHEN has a total of 11 patent applications. Its first patent ever was published in 2009. It filed its patents most often in United States, Canada and Colombia. Its main competitors in its focus markets pharmaceuticals and biotechnology are ASCENDIS PHARMA OPHTHALMOLOGY DIVISION AS, DEFENSIN THERAPEUTICS APS and GUBRA APS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 1 | |
#3 | Colombia | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Mexico | 1 | |
#6 | Peru | 1 | |
#7 | Singapore | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Evans-Freke Stephen | 11 |
Publication | Filing date | Title |
---|---|---|
US2012183536A1 | Methods of using corticotropin-releasing factor for the treatment of cancer | |
US2010203048A1 | Methods of using corticotropin-releasing factor for the use of the treatment of cancer |